PMV Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
2.92 |
16.09 |
42.42 |
89.61 |
| Przychód Δ r/r |
0.00% |
0.00% |
inf% |
450.17% |
163.63% |
111.22% |
| Przychód (min) |
0.00 |
0.00 |
2.92 |
16.09 |
42.42 |
89.61 |
| Przychód (max) |
0.00 |
0.00 |
2.92 |
16.09 |
42.42 |
89.61 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-65.25 |
-79.60 |
-96.15 |
-91.29 |
-58.80 |
-23.21 |
| Zysk netto % |
-inf% |
-inf% |
-3287.03% |
-567.31% |
-138.60% |
-25.90% |
| EPS (średnia) |
-1.26 |
-1.54 |
-1.76 |
-1.77 |
-1.14 |
-0.45 |
| Liczba analityków (Przychody) |
0 |
0 |
3 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
4 |
4 |
3 |
1 |
1 |
1 |
| symbol |
PMVP |
PMVP |
PMVP |
PMVP |
PMVP |
PMVP |